Batra J K, Jinno Y, Chaudhary V K, Kondo T, Willingham M C, FitzGerald D J, Pastan I
Laboratory of Molecular Biology, National Cancer Institute, Bethesda, MD 20892.
Proc Natl Acad Sci U S A. 1989 Nov;86(21):8545-9. doi: 10.1073/pnas.86.21.8545.
LysPE40 is a modified form of Pseudomonas exotoxin that lacks the cell-binding domain and has a chemically reactive lysine residue near the amino terminus. LysPE40 is made in Escherichia coli and secreted into the medium from which it is readily purified. Two immunotoxins were constructed by coupling LysPE40 to an antibody to the human transferrin receptor (TFR) or to an antibody to the human interleukin-2 receptor. These immunotoxins were selectively cytotoxic to receptor-bearing cells in tissue culture. Anti-TFR-LysPE40 given intraperitoneally to mice appeared rapidly in the blood and caused regression of A431 tumors growing as subcutaneous xenografts. These results show that it is possible to cause regression of a solid carcinoma by an immunotoxin if proper targeting can be achieved.
LysPE40是一种修饰形式的绿脓杆菌外毒素,它缺乏细胞结合结构域,且在氨基末端附近有一个具有化学反应活性的赖氨酸残基。LysPE40在大肠杆菌中产生并分泌到培养基中,可从中轻松纯化。通过将LysPE40与抗人转铁蛋白受体(TFR)抗体或抗人白细胞介素-2受体抗体偶联,构建了两种免疫毒素。这些免疫毒素在组织培养中对携带受体的细胞具有选择性细胞毒性。腹腔注射给小鼠的抗TFR-LysPE40迅速出现在血液中,并导致作为皮下异种移植物生长的A431肿瘤消退。这些结果表明,如果能够实现适当的靶向,免疫毒素有可能使实体癌消退。